Healthcare · Biotechnology · NASDAQ
| Market cap | $82.77B |
|---|---|
| Trailing P/E | 17.1 |
| FCF yield | 4.3% |
| Revenue growth (YoY) | +1.0% |
| EPS growth (YoY) | -2.8% |
| FCF/share growth (YoY) | +12.8% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Regeneron Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Jun 8, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Mar 12, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Dec 15, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | Jun 9, 2025 |
| Byron Donalds | House | Sell | $1,001 - $15,000 | May 24, 2025 |
| Byron Donalds | House | Sell | $1,001 - $15,000 | May 24, 2025 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | May 14, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | May 8, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | May 8, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | Mar 27, 2025 |